Search Results - "Sikirica, V."

Characterizing the relationships between patient‐reported outcomes and clinician assessments of alopecia areata in a phase 2a randomized trial of ritlecitinib and brepocitinib by Winnette, R., Banerjee, A., Sikirica, V., Peeva, E., Wyrwich, K.

“…Background The phase 2a ALLEGRO trial (NCT02974868) investigated the safety and efficacy of ritlecitinib (PF‐06651600) and brepocitinib (PF‐06700841) in adults…”
Get full text

Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes by Sikirica, Mirko V, Martin, Alan A, Wood, Robert, Leith, Andrea, Piercy, James, Higgins, Victoria

“…Nonadherence to glucagon-like peptide-1 receptor agonists (GLP1 RAs) is relatively common among patients with type 2 diabetes mellitus (T2DM). This study…”
Get full text

Patient‐Reported Outcome Measures for Severe Recurrent Bilateral Nasal Polyps: Psychometric Evaluation and Content Validity by Gater, Adam, Tolley, Chloe, Williams‐Hall, Rebecca, Trennery, Claire, Bradley, Helena, Sikirica, Mirko V., Nelsen, Linda, Sousa, Ana R., Bratton, Daniel J., Chan, Robert, Maltzahn, Robyn

“…Objective To date, no patient‐reported outcome measures have been specifically developed to assess pharmacological treatment effect in participants with severe…”
Get full text

Cost-effectiveness of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant versus long-acting stimulant monotherapy for the treatment of attention-deficit/hyperactivity disorder in Canada by Lachaine, J, Sikirica, V, Mathurin, K

Get full text

Cost-effectiveness of guanfacine extended-release versus atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder in Canada by Lachaine, J, Sikirica, V, Mathurin, K

Get full text

Characteristics and treatment patterns of children and adolescents with attention-deficit/hyperactivity disorder in real-world practice settings by Joseph, A, Davis, K, Fridman, M, Gustafsson, P, Quintero, J, Sikirica, V, Banaschewski, T

“…Objective To document patient characteristics and treatment patterns in a real-world population diagnosed with attention-deficit/hyperactivity disorder (ADHD)…”
Get full text

P.1.c.010 Access to diagnosis, treatment and supportive services: results from the caregiver perspective on pediatric ADHD study in Europe by Fridman, M, Quintero, J, Chen, K, Harpin, V, Banaschewski, T, Sikirica, V

Get full text

P.7.d.013 Guanfacine extended release for attention-deficit/hyperactivity disorder following inadequate response to prior methylphenidate by Huss, M, Hervas, A, Newcorn, J.H, Harpin, V, Lyne, A, Robertson, B, Sikirica, V

Get full text

P.7.b.011 Validation of the Weiss Functional Impairment Rating Scale – Parent Report Form in attention deficit/hyperactivity disorder by Gajria, K, Livote, E, Sikirica, V, Reilly, K, Kosinski, M, Erder, M.H

Get full text

Carer perspective on treatment, comorbidities and diagnosis of Paediatric ADHD in France by Gajria, K, Flood, E, Dietrich, C.N, Romero, B, Paillé, S, Sikirica, V

“…Objectives To examine treatment, comorbidity status and diagnosis among the French sample of the Caregiver Perspective of Pediatric ADHD (CAPPA) survey…”
Get full text

Systematic Literature Review and Mixed Treatment Comparison of Gxr Versus other Treatments in Children and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) by Joseph, A, Ayyagari, R, Bischof, M, Cai, S, Xie, M, Zhanabekova, Z, Sikirica, V

Get full text

The Impact on Work and Social Activities Among Carers of Children with Adhd in Sweden Relative to Other Nordic Countries by Romero, B, Gajria, K, Dietrich, C.N, Flood, E, Gustafsson, P.A, Ahnemark, E, Sikirica, V

Get full text

Methodological Assessment of Matching-Adjusted Indirect Comparisons: Case Study Application To Attention Deficit/Hyperactivity Disorder (Adhd) by Shafrin, J, Sikirica, V, Shrestha, A, Henkhaus, L.E, Erder, M.H, Chandra, A

Get full text

Comparison of Health Care Resource Utilization and Costs Among Children and Adolescents with Attention Deficit Hyperactivity Disorder in Germany Who Initiated Treatment with Atomoxetine or Long-Acting Methylphenidate by Curtice, T.G, Greven, P, Yeaw, J, Sikirica, V, Chen, Y.J, Setyawan, J, Makin, C

Get full text

Is Adjunctive Guanfacine-Extended Release Associated with Changes in Stimulant Adherence Among Children and Adolescents with Attention Deficit/Hyperactivity Disorder in a Managed Care Setting? by Gajria, K, Candrilli, S.D, Meyers, J, Fridman, M, Farrand, K, Hodgkins, P, Sikirica, V

Get full text

Health Care Resource Utilization and Costs Associated with Atypical Antipsychotics Use in Children and Adolescents with Attention Deficit/Hyperactivity Disorder in Quebec, Canada by Lachaine, J, Sikirica, V, De, G, van Stralen, J, BenAmor, L, Hodgkins, P, Yang, H, Heroux, J

Get full text

PMH43 Treatment Patterns, Resource Utilization and Costs Associated with Guanfacine Immediate Release Versus Guanfacine Extended Release among Children and Adolescents with Attention Deficit/Hyperactivity Disorder (ADHD) by DiBello, J, Sikirica, V, Samuelson, T, Xie, J, He, T, Erder, M.H

Get full text

EPA-0685 – Guanfacine XR (GXR) for children and adolescents with attention-deficit/hyperactivity disorder (ADHD): phase 3, randomized, double-blind, multicenter, placebo- and active-reference study by Hervas, A, Huss, M, Johnson, M, McNicholas, F, Van Stralen, J, Sreckovic, S, Lyne, A, Bloomfield, R, Sikirica, V, Robertson, B

“…Introduction GXR, a selective α2A-adrenergic agonist, is a non-stimulant treatment for ADHD (approved in the USA for children and adolescents and in Canada for…”
Get full text

PMH61 A Descriptive Analysis of Atomoxetine Utilization in Attention Deficit/Hyperactivity Disorder (ADHD) the United Kingdom and Italy by Sikirica, V, Mitra, D, Fridman, M, Davis, K.L, Hodgkins, P

Get full text

PMH37 THE COST-EFFECTIVENESS OF GUANFACINE EXTENDED RELEASE (GXR) VERSUS ATOMOXETINE (ATX) FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS by Erder, M, Chen, K, Wu, E.Q, Hodgkins, P, Sikirica, V

Get full text